Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check3 days agoChange Detected- Page revision updated from v3.3.3 to v3.3.4. This is a metadata/maintenance change with no visible impact on study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a consolidated Locations section listing California, Florida, Illinois, Massachusetts, New York, Pennsylvania, and Texas, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check53 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedThe funding/operating status notice was removed from the page. It previously served as a status banner and did not affect the study details.SummaryDifference0.4%

- Check74 days agoChange DetectedAn updated 'Last Update Posted' timestamp and minor layout adjustments are present. Core study details, eligibility criteria, and outcomes remain unchanged.SummaryDifference0.5%

- Check103 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.